IceCure Medical presents four studies at RSNA Annual Meeting with 263 patients.

IceCure Medical, a developer of minimally-invasive cryoablation technology, announced that four abstracts featuring data from independent studies using ProSense were accepted and presented at the Radiological Society of North America's Annual Meeting. The studies involved 263 patients and support broader adoption of ProSense across diverse patient populations. The RSNA's Annual Meeting is the world's largest radiology conference with around 50,000 attendees from 160 countries.